Re: Merging biojava-dev & Biojava-l mailing lists

Jose Duarte <[email protected]> Thu, 18 Jan 2018 08:14:53 -0800
Newsgroups gmane.comp.java.bio.general
Message-ID <CAHhO=JGoutdgASce9hv93Q2sdq71tR6rMzZG7WKNoPhY-4rCbA@mail.gmail.com>
--===============5309733074742282768==
Content-Type: multipart/alternative; boundary="001a11c021169d45bd05630f4300"

--001a11c021169d45bd05630f4300
Content-Type: text/plain; charset="UTF-8"

Thank you so much Peter!

On Thu, Jan 18, 2018 at 3:40 AM, Peter Cock <[email protected]>
wrote:

> Hello all,
>
> Following on from the recent emails, and OBF announcements,
> with the agreement of the BioJava team, we are merging the
> biojava-dev & Biojava-l mailing lists.
>
> https://news.open-bio.org/2017/12/15/mailing-list-consolidation/
> https://github.com/biojava/biojava/issues/717#issuecomment-357613207
>
> Specifically, all the biojava-dev subscribers are now also
> subscribed to biojava-l, and we will stop using biojava-dev.
>
> For interest, until this change the main list had 503 subscribers
> and the development list had 284. There was a lot of overlap
> as you might expect, and the combined list now has 653
> subscribers.
>
> Peter
> Open Bioinformatics Foundation (OBF) board of directors
> _______________________________________________
> Biojava-l mailing list  -  [email protected]
> http://mailman.open-bio.org/mailman/listinfo/biojava-l
>

--001a11c021169d45bd05630f4300
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr">Thank you so much Peter!<br></div><div class=3D"gmail_extr=
a"><br><div class=3D"gmail_quote">On Thu, Jan 18, 2018 at 3:40 AM, Peter Co=
ck <span dir=3D"ltr">&lt;<a href=3D"mailto:[email protected]" targe=
t=3D"_blank">[email protected]</a>&gt;</span> wrote:<br><blockquote=
 class=3D"gmail_quote" style=3D"margin:0 0 0 .8ex;border-left:1px #ccc soli=
d;padding-left:1ex">Hello all,<br>
<br>
Following on from the recent emails, and OBF announcements,<br>
with the agreement of the BioJava team, we are merging the<br>
biojava-dev &amp; Biojava-l mailing lists.<br>
<br>
<a href=3D"https://news.open-bio.org/2017/12/15/mailing-list-consolidation/=
" rel=3D"noreferrer" target=3D"_blank">https://news.open-bio.org/<wbr>2017/=
12/15/mailing-list-<wbr>consolidation/</a><br>
<a href=3D"https://github.com/biojava/biojava/issues/717#issuecomment-35761=
3207" rel=3D"noreferrer" target=3D"_blank">https://github.com/biojava/<wbr>=
biojava/issues/717#<wbr>issuecomment-357613207</a><br>
<br>
Specifically, all the biojava-dev subscribers are now also<br>
subscribed to biojava-l, and we will stop using biojava-dev.<br>
<br>
For interest, until this change the main list had 503 subscribers<br>
and the development list had 284. There was a lot of overlap<br>
as you might expect, and the combined list now has 653<br>
subscribers.<br>
<br>
Peter<br>
Open Bioinformatics Foundation (OBF) board of directors<br>
______________________________<wbr>_________________<br>
Biojava-l mailing list=C2=A0 -=C2=A0 <a href=3D"mailto:[email protected]=
en-bio.org">[email protected]</a><br>
<a href=3D"http://mailman.open-bio.org/mailman/listinfo/biojava-l" rel=3D"n=
oreferrer" target=3D"_blank">http://mailman.open-bio.org/<wbr>mailman/listi=
nfo/biojava-l</a><br>
</blockquote></div><br></div>

--001a11c021169d45bd05630f4300--

--===============5309733074742282768==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline

_______________________________________________
Biojava-l mailing list  -  [email protected]
http://mailman.open-bio.org/mailman/listinfo/biojava-l
--===============5309733074742282768==--